Treatment of Epilepsy with Myoclonic Atonic Seizures When Second-Line Therapy Has Not Achieved Seizure Control

In epilepsy with myoclonic atonic seizures, treatment is escalated stepwise. When a second-line regimen has been trialled adequately and the patient has not reached the expected seizure reduction or seizure freedom, a defined third-line approach is indicated.

Second-Line Failure — When This Protocol Applies

This third-line protocol is indicated after second-line therapy — including ethosuximide, the combination of valproate and ethosuximide, or the ketogenic diet — has not achieved a greater than 50% reduction in seizures or seizure freedom. The failure of these second-line options, whether used individually or in combination, is the trigger for escalation.

Third-Line Approach

At the third line, a combination approach incorporating specific medication classes is used to address generalised seizures. The full protocol specifies the agents involved, their roles in combination, and the decision points guiding their use.

Complete regimen details — including sequencing, combination specifics, and clinical decision criteria — are available in the full structured protocol below.

Instant Access to Structured Evidence-Based Regimens

References

The Delphi consensus recommended valproate and benzodiazepines (either alone or in combination) and the ketogenic diet for treatment during the stormy phase; steroids can also be considered.

View source ↗